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SUMMARY
Maternal-offspring gene interactions, aka maternal-fetal genotype (MFG) incompatibilities, are 
neglected in complex diseases and quantitative trait studies. They are implicated in birth to adult 
onset diseases but there are limited ways to investigate their influence on quantitative traits. We 
present the Quantitative-MFG (QMFG) test, a linear mixed model where maternal and offspring 
genotypes are fixed effects and residual correlations between family members are random effects. 
The QMFG handles families of any size, common or general scenarios of MFG incompatibility, 
and additional covariates. We develop likelihood ratio tests (LRTs) and rapid score tests and show 
they provide correct inference. In addition, the LRT’s alternative model provides unbiased 
parameter estimates. We show that testing the association of SNPs by fitting a standard model, 
which only considers the offspring genotypes, has very low power or can lead to incorrect 
conclusions. We also show that offspring genetic effects are missed if the MFG modeling 
assumptions are too restrictive. With GWAS data from the San Antonio Family Heart Study, we 
demonstrate that the QMFG score test is an effective and rapid screening tool. The QMFG test 
therefore has important potential to identify pathways of complex diseases for which the genetic 
etiology remains to be discovered.
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Maternal and offspring gene interaction, also termed maternal-fetal genotype (MFG) 
incompatibility, occurs when the effects of maternal genes on the offspring’s phenotype vary 
depending on the offspring’s genotype. The possibility of joint maternal and offspring 
effects needs to be studied, especially when investigating genetic factors of developmental 
disorders and their associated quantitative traits. Previous studies have found that MFG 
interactions are associated with preterm birth, conotruncal heart defects, neural tube defects, 
and preeclampsia (see as examples, Liang et al., 2010, Li et al., 2014, Lupo et al., 2014, 
Procopciuc et al., 2014). Additionally, MFG incompatibilities have been implicated as risk 
factors in complex adult onset diseases, such as schizophrenia, where the effects are not 
evident until long after the MFG incompatibility initiated event has occurred and subsided 
(see as examples, Stubbs et al., 1985, Hollister et al., 1996, Dahlquist et al., 1999, Juul-Dam 
et al., 2001, Cannon et al., 2002, Palmer et al., 2002, Newton et al., 2004, Insel et al., 2005, 
Palmer et al., 2008, Freedman et al., 2011). To date, studies have not looked at the role of 
MFG incompatibility on the quantitative traits related to these adult onset diseases. Although 
there are a number of methods for investigating MFG incompatibility as a risk factor for 
disease (see Sinsheimer & Creek, 2013 for a review of these methods), the proposed 
methods to investigate the effects of maternal and offspring genes on quantitative traits 
typically rely on retrospective likelihoods and are limited to case-parent trios (Kistner & 
Weinberg, 2004, Kistner & Weinberg, 2005, Wheeler & Cordell, 2007). Moreover, the 
retrospective likelihood design is not easily generalized to arbitrary family structures, 
multiple markers, or multivariate traits (Kraft et al., 2004) and parameter interpretation can 
be challenging.
One way to conduct association testing with quantitative traits using pedigree data is in a 
measured genotype analysis (Boerwinkle et al., 1986, Lange, 2002). This method of testing 
uses a linear mixed model (LMM) in which the genotypes are fixed effects and familial 
correlations are taken into account through partitioning the variance. Hence the LMM is also 
called variance component modeling in the genetic literature. We have developed the 
Quantitative-MFG (QMFG) test, an extension to the LMM where the joint maternal and 
offspring effects including MFG incompatibilities are fixed effects, familial correlations are 
variance components, and the outcome is a trait with residuals that are reasonably modeled 
as normally distributed (Lange, 2002). This approach handles pedigrees of virtually any size, 
both general and specific scenarios of MFG incompatibility, multivariate traits, and 
covariates in a straightforward manner. Another advantage of this approach is the ability to 
quickly test genome-wide association study (GWAS) pedigree data for joint maternal and 
offspring effects including MFG incompatibility via the use of the score test.
MATERIALS AND METHODS
The QMFG Test
Recall that, for a single pedigree, the general multivariate normal loglikelihood for a LMM 
is
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with observed trait vector y, mean vector ν, and covariance matrix Ω (see for example, 
Lange, 2002 for details regarding the variance component model in classic genetic 
applications). We propose an extension to this model where the maternal-offspring 
genotypes are fixed effects. In the QMFG test, ν = Aβ, where A is the design matrix 
consisting of indicator variables for the MFG combinations of interest and β is the column 
vector of corresponding regression coefficients. In our applications, ν always includes a 
grand mean μ so there is one entry of β that equals μ and one column of A is all ones. 
Consider the effects of a single SNP with a reference allele and a variant allele. When 
modeling the joint effects of maternal and offspring genotype effects, let βamac denote the 
difference in the offspring’s quantitative trait value from the grand mean for a mother with 
am variant alleles and an offspring with ac variant alleles at a given SNP. Because there are 
seven possible mother-offspring genotype combinations for a biallelic locus (see Table 1), in 
the general MFG incompatibility case for one SNP, the vector of regression coefficients is βt 
=(μ, β00, β01, β10, β11, β12, β21, β22) and the additional columns of the design matrix A are 
indicator variables corresponding to each of the seven possible MFG combinations. Note 
that just as additional covariates such as age and sex can be incorporated in the standard 
measured genotype analysis (Boerwinkle et al., 1986), they can be included in the fixed 
effect portion of the QMFG model as additional entries in theβ vector and additional 
columns of the A matrix. To avoid non-identifiability, one of the parameters for the MFG 
effects should be made the reference state or, equivalently, the sum of MFG parameters 
should be set to some constant. In our analyses, parameter β00, denoting zero copies of the 
variant allele in both mother’s and offspring’s genotypes, is always set to zero and hence, at 
most six MFG parameters are estimated along with the grand mean.
We continue to treat familial correlations as random effects by partitioning the residual 
variance. Here we define the partition of the covariance matrix as , where k is 
the number of variance components included in the model. Often in genetic studies a very 
simple version of this matrix with only two components is used, one representing the 
additive genetic effects and one representing environmental random effects. In this model, 
the familial correlations are assumed to be due to small and approximately equal effects of 
alleles at a number of genes each acting independently. The additive genetic and 
environmental variances are denoted by  and , respectively. The design matrix Γa 
corresponding to  is twice the global kinship coefficient matrix Φ. Each element Φij is the 
probability that, at a randomly chosen autosomal locus, an allele chosen at random from 
subject i and an allele chosen at random from subject j match identically by descent. When i 
equals j the alleles are chosen with replacement. The environmental contribution is 
multiplied by the identity matrix I since the environment is assumed to affect each subject 
independently. The environmental variance  is always included even when there are 
thought to be no environmental factors to insure that the matrix is positive definite. Under 
this simple model, .
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As in other LMM scenarios, likelihood ratio tests (LRTs) can be used here to determine the 
significance of MFG parameters. Asymptotically, the LRT statistic follows a chi-square 
distribution with degrees of freedom equal to the difference in the number of parameters 
under the null and alternative models. In addition to the LRT, we can use score tests to 
rapidly screen markers (Chen & Abecasis, 2007). The score statistic is given by
where ∇L(θ) is the gradient of the loglikelihood with the parameter vector θ, dL(θ) is the 
first differential of the loglikelihood, and J(θ) is the expected information matrix. Zhou et al. 
(2015) precompute and store key quantities for a fast score test for individual SNPs. In 
particular, for family i under the alternative hypothesis, the design matrix Ai can be written 
as (ai, Ni) where Ni is the design matrix under the null. Additional covariates are included in 
the matrix Ni. The array ai conveys the genotypes at the SNP of interest. Let the residual for 
family i be ri = yi − Niβ̂ where β̂ are the maximum likelihood estimates (MLEs) of the fixed 
effects under the null (in which no SNPs are included in the model). The score statistic for n 
families then reduces to
where
Thus the quantities , and  can be computed once under 
the null model and then reused for the analysis of each SNP. This makes the calculation of 
the score test statistic for each SNP simple and rapid.
We extend this fast calculation of the score test to MFG incompatibility by replacing ai, 
which previously was a vector conveying the variant allele counts at the SNP of interest for 
family i, with the matrix Xi. In its most general form, each column of matrix Xi represents 
one of the possible maternal-fetal genotype combinations and is composed of zeros and 
ones, indicating which MFG combination defines the joint mother-offspring genotype for 
each offspring within the pedigree at a particular SNP. For example, for the pedigree in 
Figure 1
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and for the pedigree in Figure 2
In these examples, the top row corresponds to Offspring A and the bottom row corresponds 
to Offspring B and each column corresponds to the maternal-fetal genotype combinations in 
Table 1. The columns of Xi can be combined depending on the restrictions imposed on the 
parameters and therefore the number of columns equals the number of parameters to be 
estimated. As with the LRT, the score test statistic asymptotically follows a chi-square 
distribution with degrees of freedom determined by the difference between the number of 
parameters in the null and alternative models.
There are advantages and disadvantages to both the LRT and the fast score test. For 
example, dealing with complex null and alternative hypotheses is better handled with the 
LRT. However, to calculate the LRT iterative maximization of the likelihood under both the 
null and alternative models is required, which can be computationally intensive when using 
large numbers of extended pedigrees and markers. We evaluate the ability of both tests to 
make correct QMFG inferences. Another advantage of the LRT is that in maximizing the 
likelihood we obtain parameter estimates. We also evaluate the accuracy and precision of 
these estimates.
Examples of MFG Incompatibility
To better illustrate how the QMFG model works, we present two well-known examples of 
MFG incompatibility. Although these two examples are typically framed in terms of disease, 
they could easily be imagined to be operating on associated quantitative traits. First, we 
consider the case where the mother reacts to antigens created by the offspring. The 
prototypical example is RHD incompatibility (Figure 1), which occurs if the mother is 
homozygous for the variant allele ‘d’ (RHD-negative) and the offspring is heterozygous 
(RHD-positive). This can lead to hemolytic disease of the newborn (Levine et al., 1941), 
which is associated with high levels of bilirubin resulting from the breakdown of the fetus’s 
red blood cells (Lee et al., 2009). In our simulation study we estimate parameter β21, which 
denotes the expected change in the quantitative trait value of the offspring when mother and 
offspring are RHD incompatible, and the other six MFG parameters form the reference 
group, i.e., β00 = β01 = β10 = β11 = β12 = β22 = 0 (Table 1, Column 4).
The second example we investigate is the case where the offspring’s immune system reacts 
to an antigen that has its origins in the mother’s genotype. It is inspired by rheumatoid 
arthritis (RA) and HLA-DRB1, where non-inherited maternal antigens (NIMA) have been 
implicated in offspring disease susceptibility (van der Horst-Bruinsma et al., 1998, Harney 
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et al., 2003, Newton et al., 2004). As an example of an associated quantitative trait, anti-
CCP antibodies are important markers for diagnosis and prognosis in RA since they are 
highly specific and sensitive (Visser et al., 2002, Silveira et al., 2007) and therefore would 
be an interesting quantitative trait to investigate using the QMFG test. A pedigree depiction 
of NIMA is shown in Figure 2 and is characterized by a mother that has one variant allele 
encoding a shared epitope (SE-positive) and an offspring that has none (SE-negative). There 
is strong evidence that there is an effect when the offspring has one or more variant alleles 
regardless of the mother’s genotype (Gregersen et al., 1987, Jawaheer & Gregersen, 2002) 
and thus offspring effects must be included in the model. This model allows us to show how 
more complex restrictions can be handled. As shown in Table 1, Column 5, the effects of 
interest are the NIMA effect (β10) and the offspring genotype effects (β.1 = β01 = β11 = β21 
and β.2 = β12 = β22).
Mendel Software
We implement the QMFG test by modifying the statistical genetics software package 
Mendel (Lange et al., 2013). When using SNPs, one allele is considered the reference allele 
and the other is the derived, variant allele. In order to implement the measured genotype 
analysis option for MFG incompatibility, the Mendel code was updated to extract the variant 
allele counts for mother and offspring from the genotypes included in the pedigree files. The 
reference allele is by default the more frequent allele but this can be changed if the user 
specifies in the Mendel control file. Once variant allele counts are determined, the LRT 
option is run by internally including a new covariate for each offspring that indicates which 
of the seven possible maternal-fetal gene-gene combinations describes the offspring’s and 
his mother’s genotypes. This enables MFG incompatibility parameters to be estimated and 
the likelihood to be calculated within the variance component analysis option in Mendel. 
The user can place restrictions on parameter estimates thus allowing for specific forms of 
MFG incompatibility such as offspring antigen – maternal antibody (referred in this 
document by the prototypical example RHD incompatibility) or maternal antigen – offspring 
antibody (referred in this document by the prototypical example NIMA). To program the 
QMFG score test, we used much of the machinery in the existing ped-GWAS option in 
Mendel that implements an LMM-based fast score test for GWAS on pedigree data with 
quantitative traits (Zhou et al., 2015). We forced the existing algorithm to include in its 
model the seven possible maternal-fetal genotype combinations and any user-specified 
restrictions on these combinations.
Simulation of Pedigrees
To evaluate the type I error or power of the QMFG tests and, for the LRT implementation, 
parameter estimation, we simulate data under ten specific scenarios (A-J) using the 
parameters shown in Table 2. Simulation A data are under the null of no genetic effects. 
Simulations B, E, and H involve conditions consistent with the effects of RHD 
incompatibility. Simulations C, D, F, and I are consistent with the effects of NIMA with and 
without the additional effects of offspring alleles and maternal effects. Simulation G is 
another possible scenario where each variant allele in the mother or offspring has the same 
effect on the phenotype and the effects are additive and independent; it is a special case of a 
scenario where there are both maternal and offspring main effects but no interaction. We use 
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Simulation G when we want to evaluate the properties of fitting the general model. 
Simulation J involves offspring effects only and is used to investigate model 
misspecification. For power analyses, we vary selected parameters of particular interest in 
these simulation scenarios. The simulation design consists of 2,000 repetitions of 1,000 
three-generational pedigrees (except when studying the effect of family structure or sample 
size), a biallelic locus, and a quantitative trait. Every three-generational pedigree is 
comprised of a nuclear family with two offspring, each of which have a partner and child of 
their own, and therefore the extended family contains a total of four founders and four 
offspring. Unless otherwise specified, the variant allele frequency is 0.40. Genotypes are 
simulated using Mendel’s gene dropping option. Additional effects include a grand mean 
(intercept) μ = 40 and variance components  and  (residual heritability h2 = 0.167) 
unless otherwise specified. A univariate quantitative trait is simulated for all offspring by 
modifying the trait simulation option of Mendel (Lange et al., 2013).
Assessing the Statistical Properties of the Tests
We use a variety of full and reduced models (Table 3, Models 1–9) to analyze the simulated 
data, the exact choice depending on our alternative and null hypotheses. All models fit to the 
data estimate a grand mean (μ) and both variance components (  and ). To quantify the 
degree of bias in type I error, genomic control values (λ) are reported (Devlin & Roeder, 
1999) and 95% confidence bounds are included on Q-Q plots. Confidence bounds are based 
on the standard errors of the order statistics of the comparison distribution (Fox, 2008).
Power is defined as the rejection rate, which is the proportion of simulations in which the 
statistical test rejects the null model in favor of the alternative. If not otherwise specified, we 
used a per test significance level of 0.001 when determining power. Standard errors of 
power estimates are calculated using  where p is the proportion of rejected 
tests and N is the number of repetitions. The proportion of variation explained is calculated 
as the ratio of phenotypic variation due to the effects of interest and the total phenotypic 
variation, and is based on the true parameter values and allele frequencies with which the 
data are simulated.
The San Antonio Family Heart Study
To show the feasibility of using this approach on a real pedigree-based GWAS dataset, we 
use data from the San Antonio Family Heart Study (SAFHS). These data have described 
elsewhere (Mitchell et al., 1996) but we briefly describe the subset of the data we use. The 
complete study data consist of 3637 subjects in Mexican American families of various sizes. 
High-density lipoprotein (HDL) levels were measured at up to three time points. For the first 
time point, 1,397 individuals were phenotyped (Table S1). Of the subjects that were 
phenotyped, 1,043 also have genotype data. To reduce the computational time used to 
impute missing genotypes for irrelevant members of the pedigree, we first trim the data to 
include only subjects with a quantitative trait measurement and their connecting relatives 
(Lange & Sinsheimer, 2004). Because the QMFG test is an offspring-only analysis, we are 
interested in the subset of 855 offspring in the dataset that have both phenotype and 
genotype data. If an offspring’s mother is completely ungenotyped before imputation, they 
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were not used. Our analysis therefore involves the 419 offspring from 43 families with 
phenotype, genotype, and maternal genotype information. In this subset of data, the largest 
family has 176 members and 5 generations while the smallest family has 8 members and 3 
generations. Next, we use Mendel’s imputation option to fill in all missing genotypes for 
subjects who have some existing SNP data (Ayers & Lange, 2008). Standard imputation 
programs, which do not take pedigree data into account, inevitably produce impossible 
maternal-offspring genotype combinations. We remove SNPs that have a maternal and 
offspring genotype combination of either 2/2 and 1/1, respectively, or 1/1 and 2/2, 




We first compare type I error rates of the LRT and score test for a simple example of 
maternal-fetal gene interactions that mimics RHD incompatibility. In this example, 
heterozygous offspring whose mothers who are homozygous for the variant allele differ in 
their trait value from other offspring. Figure 3a shows the results when data are simulated 
under the null hypothesis of no genetic effects (Simulation A) and the parameter β21 is tested 
for significance. For the LRT, Model 1 reflects the null hypothesis and Model 2 reflects the 
alternative hypothesis, resulting in a one degree of freedom (df) test. The QMFG score test 
provides almost identical results (Figure S1a). Based on the confidence bounds on the Q-Q 
plot, we conclude there is little bias in the type I error for either test (genomic control value 
λ = 1.065). Next, data are simulated to provide a moderately small RHD effect (Simulation 
B). In Simulation B, the only effect associated with the offspring’s phenotype is an expected 
increase of 0.55 units when mother and offspring are incompatible, corresponding to 0.0044 
of the variance explained by the RHD effect. Figure 4a provides boxplots of the parameter 
estimate bias over 2,000 replicates when the underlying MFG mechanism, RHD 
incompatibility, is suspected and consequently the correct model, Model 2, is fit to the data. 
As desired, the QMFG method produces unbiased parameter estimates. Keeping all other 
simulation conditions the same, we then varied the true RHD effect between 0 and 0.7, 
resulting in the true proportion of variation explained by the MFG effect ranging from 0 to 
0.007. Figure 5a shows the LRT and score test power curves corresponding to these 
variations for the one degree of freedom test (solid lines) testing the significance of the RHD 
parameter (β21). When the significance level is 0.001, the curve illustrates that 80% power is 
achieved when the proportion of variation explained by the RHD effect is approximately 
equal to 0.004 for both the LRT and score test.
Non-inherited Maternal Antigen (NIMA) Effects
The case of NIMA provides a more complex model under which to investigate the 
properties of the QMFG test due to the added offspring allelic effects. For this more 
complicated case of MFG incompatibility, we start by comparing the LRT and score test 
type I error rates. Model 1 corresponds to the null hypothesis of no genetic effects and 
Model 3 corresponds to the alternative hypothesis of offspring or NIMA effects. By fitting 
Models 1 and 3 to data simulated with no genetic effects (Simulation A), the three degrees 
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of freedom LRT results in the Q-Q plot in Figure 3b (λ = 0.989). Figure S1b shows that the 
score test for the significance of the same three parameters (β10, β.1, β.2) is a suitable 
substitute for the LRT as it yields nearly identical p-values. As mentioned previously, using 
the LRT we can test the significance of NIMA in the presence of offspring effects or the 
offspring effect in the presence of NIMA. Figure 3c is the Q-Q plot (λ = 1.048) of the results 
of testing the significance of the NIMA parameter while allowing for offspring genotype 
effects (Model 3 vs Model 4) and Figure 3d is the Q-Q plot (λ = 0.959) of the results for 
offspring parameters in the presence of NIMA effects (Model 3 vs Model 5). Together these 
three Q-Q plots (Figure 3b–d) and confidence bounds demonstrate that our type I error rates 
are correct.
In Simulation C, a quantitative trait is simulated for offspring with a NIMA effect of 0.6 and 
an additive offspring allelic effect of 0.18 per allele, corresponding to 0.0058 of the variance 
explained by the combination of MFG and offspring effects. Mimicking a situation where 
there is a priori evidence for a particular model (in this case, NIMA and offspring effects), 
we fit Model 3 to the simulated data thus estimating three parameters (β10, β.1, β.2) in 
addition to the variance components when using the LRT. The bias of each parameter 
estimate is shown in Figure 4b. As a valid method should, the QMFG method generates bias 
centered at zero. We further evaluate power over 2,000 simulation replicates for varying 
levels of proportion of variation explained for this model (Model 3). The power curves in 
Figure 5b are the results of jointly testing for NIMA or offspring effects (solid lines) when 
the simulated NIMA effect sizes range from 0 to 0.7 and the offspring effects are β.1 = 0.18, 
and β.2 = 0.36. These simulation parameters are consistent with proportion of variation 
explained ranging from 0.002 to 0.008. The power to detect NIMA or offspring effects 
(three degrees of freedom test) is approximately 80% when proportion of variation 
explained reaches 0.0055 for both the LRT and the score test. Figure S2 displays the power 
of the LRT for testing the significance of the NIMA effect in the presence of offspring 
genotype effects (one degree of freedom test) using the same collection of data. Power is 
approximately 80% when the proportion of variation explained by the NIMA effect reaches 
0.002.
The NIMA analyses mentioned above are free of constraints on the relationship between 
offspring allelic effect parameters β.1 and β.2, that is, a genotypic model. Offspring effects 
may act in an additive, recessive or dominant manner. If there is a priori evidence to suggest 
any of these models, it is possible to impose restrictions on these parameters for the models 
that are fit, therefore reducing the degrees of freedom and increasing power. To demonstrate 
the ability of the QMFG LMM to handle such a situation, we simulate data with a NIMA 
effect varying from 0 to 0.6 and dominant offspring effects equal to 0.1 and analyze the data 
estimating again the NIMA and offspring effects, this time imposing the additional 
constraint β.1 = β.2. Figure S3 shows the power curves resulting from testing for a NIMA or 
dominant offspring effect. For the LRT, this involves using Model 1 corresponding to the 
null hypothesis and Model 6 corresponding to the alternative hypothesis, resulting in a two 
degrees of freedom test. The power to detect these effects remains high. There is greater 
than 80% to detect NIMA or dominant offspring effects when the proportion of the variance 
explained by these effects is 0.006.
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Thus far, we have considered scenarios where just MFG and offspring effects are present. It 
is possible that in addition to these effects, there are maternal effects. To further demonstrate 
the flexibility of the QMFG method, we simulate data with both maternal and offspring 
main effects such that each variant allele further increases the offspring’s trait by 0.18 
(Simulation D). In this scenario, the proportion of variation explained by the NIMA, 
offspring, and maternal effects is 0.009. For this specific scenario, we fit Model 1 
corresponding to the null of no genetic effects and Model 7 corresponding to our alternative 
hypothesis. Model 7 is a five parameter model that is mathematically equivalent to 
genotypic offspring main effects, genotypic maternal main effects and a NIMA effect. 
Parameterized through using the coefficients for seven possible maternal-offspring genotype 
combinations, Model 7 requires an additional constraint β22 + β11 − β12 − β21 = 0 in addition 
to β00 = 0. In other words, one of the parameters, β11, β12, β21, β22, is completely determined 
by the other three and so when using a LRT, five MFG parameters are tested (e.g. β01, β10, 
β11, β12, β21). Figure S4 shows that there is no parameter estimate bias when we fit Model 7 
to the data. The power of the LRT for this five degrees of freedom test is 0.96 (SE=0.004).
Effects of Allele Frequency and Variance Parameters
In the previous sections, the variant allele had a frequency of 0.4. For RHD incompatibility 
we consider ‘d’ to be the variant allele and for NIMA we consider the alleles encoding a 
shared epitope (SE+) to be variant. To evaluate the effect of allele frequency on our QMFG 
method, we compare our power results for Simulations B and C while varying the variant 
allele frequency from 0.1 to 0.9. Figures S5a and S5b show the impact of changing the 
variant allele frequency keeping the other simulation parameters the same for Simulations B 
and C, respectively. The power is maximized when the frequency of the ‘d’ allele is 0.67 for 
data simulated under RHD incompatibility. Under NIMA and offspring effects, power is 
maximized when the SE+ allele frequency is 0.33.
We also investigate the performance of the QMFG test when the values for additive genetic 
and environmental variance are changed, increasing the residual heritability. We recreate the 
power curves for RHD incompatibility as well as for NIMA and offspring effects, this time 
changing both the additive genetic and environmental variance simulation values to 3 
( , h2 = 0.50). Repeating the same one degree of freedom test for an RHD effect 
with these new variance values, we see an increase in power (Figure S6a) over our previous 
results (Figure 5a). Repeating the same three degrees of freedom test for NIMA or offspring 
effects using data simulated with these new variance values, we also see an increase in 
power (Figure S6b) over our previous results (Figure 5b).
Effects of Family Structure and Sample Size
To address the impact of family structure on our MFG tests, we simulate 4,000 trios, 
keeping the total number of offspring at 4,000, with quantitative traits with the same 
simulation parameters in Simulations B and C. With linear mixed models the additive and 
environmental variances are confounded when using a single individual per pedigree so 
instead of estimating  and  separately, we estimate their sum. Figure S7a shows there is 
no parameter estimate bias when fitting Model 2 to data simulated under RHD 
incompatibility (Simulation B). Power for either the LRT or the score test to detect an RHD 
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effect (Model 2 vs Model 1) is not significantly altered. It is 0.81 (SE = 0.009) for three-
generational families and 0.79 (SE = 0.009) for trios. Parameter estimates also remain 
unbiased (Figure S7b) when using trios with a quantitative trait simulated with NIMA and 
offspring effects (Simulation C) when fitting Model 3. Power with the three degrees of 
freedom test for NIMA or offspring effects (Model 3 vs Model 1) is not significantly 
changed. It is 0.82 (SE = 0.009) for three-generational families and 0.85 (SE = 0.008) for 
parent-offspring trios.
It is important to also consider the effect of sample size on the statistical properties of the 
tests. Here we run simulations with a smaller sample of 400 offspring from 100 three-
generational families. As shown in Figure S8, type I error rates remain unaffected by a 
reduction in sample size. To achieve equivalent power to 1,000 families, we need to increase 
the RHD effect to 1.75. Fitting Model 2 to 100 three-generational families simulated with 
quantitative traits given Simulation E parameters, results in no bias for grand mean, RHD, 
and environmental variance parameters (Figure 6). Additive variance is slightly 
underestimated. The power to detect an RHD effect, which accounts for 0.042 of the trait 
variance in this scenario, is 0.78 (SE = 0.009). To achieve equivalent power to 1,000 
families, we need to increase effect sizes for NIMA and offspring effects (Model 3) to β01 = 
1.90, β.1 = 0.60, β.2 = 1.20 when generating data for 100 three-generational families 
(Simulation F). We again see no bias for grand mean, NIMA, offspring, and environmental 
variance parameters (Figure S9). Additive variance is again slightly underestimated over the 
2,000 repetitions. The proportion of variation explained by the NIMA and offspring effects 
in this scenario is 0.056 and the power for the three degrees of freedom test for NIMA or 
offspring effects is 0.82 (SE = 0.009).
Analysis when the MFG Mechanism is Unknown
Our QMFG analyses thus far assume that our outcome is associated with two well-known 
mechanisms of MFG incompatibility. However, it may be that there is no a priori 
information about the underlying MFG model that influences a trait’s value. Thus, we study 
the effects of using the general model, which imposes no constraints on the MFG 
parameters. First, we investigate the properties (type I error, power, and parameter 
estimates) of fitting such a model. Figure 3e shows the Q-Q plot for data simulated under the 
null hypothesis of no genetic effects (Simulation A) where all six MFG parameters β01, β10, 
β11, β12, β21, β22 are tested for significance (λ = 1.086). This is a six degrees of freedom test 
in which the full model (Model 8) is tested against the null model in which no MFG effects 
are estimated (Model 1) via the LRT. All the points lie within the confidence bounds; there 
is no bias in the type I error rate. The score test produces equivalent p-values (not shown). 
Parameter estimate bias is examined by simulating data given a count model (Simulation G). 
In Simulation G, each variant allele in the mother or offspring increases the offspring’s 
phenotype by 0.17 and the effects are additive and independent. In this scenario, 0.007 of the 
variance is explained by the MFG effect. Figure 4c shows the boxplots of the parameter 
estimate bias over 2,000 replicates when the general model is fit to the data. Again, unbiased 
parameter estimates are produced.
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It is also of interest to examine the degree to which parameter estimate precision is reduced 
and power is lost when the underlying MFG model requires a less complex model, such as 
RHD or NIMA, but agnostically, the general model is fit. We consequently repeat the 
analysis of Simulations B and C, this time fitting the general six-parameter model (Model 
8). As the boxplots displayed in Figures S10a and S10b illustrate, parameter estimates 
remain unbiased. The effect on power is visible in Figures 5a and 5b (dotted lines). As 
expected, the power curves follow a similar pattern to those from less complex models but 
are lower for both RHD incompatibility and NIMA examples. Under Simulation B 
conditions, the power of the LRT when α = 0.001 reduces from 0.751 (SE = 0.010) to 0.467 
(SE = 0.011) when the proportion of variation explained is 0.0044. Under Simulation C 
conditions, the power of the LRT at the same significance level reduces from 0.823 (SE = 
0.009) to 0.702 (SE = 0.010) when the proportion of variation explained is 0.0058. These 
results demonstrate that in terms of power, the QMFG test performs well when there is no 
prior support for a restricted model, thus avoiding possible model misspecification or 
misinterpretation. However, when there is prior support for a specific model (such as RHD 
incompatibility or NIMA), a restricted model can provide a substantial increase in power.
Power to Detect MFG Incompatibility in a Standard GWAS Analysis
Can a typical GWAS, which tests the effects of an offspring’s genotype and ignores MFG 
interactions, be used as a first screen for MFG incompatibility? We address this question by 
using data simulated with RHD incompatibility effects ranging from 0 to 0.70 and 
comparing the power shown in Figure 5a with the power that results when testing for either 
offspring genotypic and additive effects. Figure 7 shows the two degrees of freedom test for 
an offspring genotypic effect model and the one degree of freedom test for an additive 
offspring allelic effect model with significance levels α = 0.05 (Figure 7a) and α = 0.001 
(Figure 7b). For the LRT, the two degrees of freedom test involves fitting Models 1 and 4 
and the one degree of freedom test involves fitting Models 1 and 9. Together these figures 
demonstrate that, compared to the correct test for an RHD effect, power is drastically 
reduced. In the case of a true underlying RHD effect of 0.70 (Simulation H), the parameters 
representing the effect of one variant allele in the offspring genotype (β01, β11) are biased 
upward when fitting the offspring only genotypic model (Figure S11a). The parameter 
representing the effect of being homozygous for the variant allele remains unbiased. The 
parameter for the offspring allelic effect is only slightly upwardly biased when fitting the 
additive model (Figure S11b). We repeat both the two degrees of freedom test for offspring 
effects and one degree of freedom additive offspring effects analyses in data simulated with 
a NIMA effect ranging from 0 to 0.7 and no offspring effect. Figure 8 shows the resulting 
power curves for α = 0.001. In this case, the power is not as severely reduced. However, 
when fitting the genotypic model to data with a true NIMA effect of 0.7 (Simulation I), we 
see a downward bias of offspring genotype parameter estimates (Figure S12a). Figure S12b 
also shows there is parameter estimate bias when the additive model is fit to Simulation I 
data. Thus in the case of NIMA, a user may very well reject the null hypothesis but 
mistakenly attribute the effect to the offspring’s genotype.
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We find that an RHD effect is unlikely to be detected if an investigator uses a NIMA effect 
model. For instance, if we take data with a true RHD effect of 0.7 (Simulation H), power 
drops from 0.97 (SE = 0.004) when the correct RHD effect model (Model 2) is fit to 0.008 
(SE = 0.002) when an incorrect NIMA effect model is fit (Model 5). Although the parameter 
for a NIMA effect, β10, is estimated on average to reduce the quantitative trait (Figure 
S13a), the estimate would not likely be found significant. Thus in the event that the model is 
misspecified, an RHD effect would not be misinterpreted as a NIMA effect but instead it 
would be missed. Likewise, misspecifying the QMFG model as an RHD effect model 
(Model 2) when data have a true underlying NIMA effect of 0.7 (Simulation I) would result 
in a missed effect. In this case, power drops from 0.999 (SE = 0.001) when the correct 
NIMA model is fit (Model 5) to 0.004 (SE = 0.001) when an incorrect RHD model is fit 
(Model 2). As shown in Figure S13b, the RHD parameter (β12) is on average estimated to 
decrease the phenotype, though it would seldom be found significant given similar sample 
and effect sizes and therefore the NIMA effect would not be misinterpreted as an RHD 
effect. In both cases, although the true MFG effect would be missed, detecting false MFG 
effects is unlikely.
In Simulation J, a quantitative trait is simulated for offspring with an additive offspring 
allelic effect of 0.27. Mimicking a situation where the user incorrectly hypothesizes that 
there is an RHD effect on the quantitative trait, we fit Model 2 to the simulated data thus 
estimating the RHD parameter (β21). Under these conditions where we would have power 
equal to 0.86 (SE= 0.008) if the correct model for offspring effects (Model 4) was used, the 
rejection rate when testing for an RHD effect is 0.002 (SE = 0.001). Figure 9a shows the 
degree of parameter estimate bias that follows from misspecifying the model. Taken 
together, these results show that it is possible that an offspring effect would be 
misinterpreted as an RHD-like effect that reduces the trait value, but that the null hypothesis 
of no RHD effect would rarely be rejected. If a user instead believes there may be a NIMA 
effect on phenotype, he or she may fit Model 3 (NIMA and offspring effects model) or 
Model 5 (NIMA effect only model) to the data. Because the NIMA and offspring effects 
model includes parameters for offspring allelic effects, we expect that the estimated 
parameters would not be biased although the power would be reduced. These expectations 
are confirmed by Figure 9b and the power for the three degrees of freedom test for NIMA or 
offspring effects is 0.81 (SE = 0.009). On the other hand, if the NIMA effect model (Model 
5) is fit to the same data, the power when testing for a NIMA effect is 0.16 (SE = 0.008). 
The potential to reject the null hypothesis is higher than in the case of RHD, but a significant 
effect would probably not be detected. In Figure 9c it can be seen that if there was enough 
power, the offspring effect might be misinterpreted as a NIMA effect that decreases the 
quantitative phenotype. Finally, if the user has no a priori hypothesis and fits the most 
general model (Model 8), there is zero bias (Figure 9d) and the power to detect an effect is 
0.69 (SE = 0.010). These results further demonstrate the advantage of using an MFG model 
that allows for offspring effects, which is a generalization of the standard GWAS analysis, 
when screening for MFG effects.
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Effect of Missing Data on Type I Error
As is often the case with real data, missing data are an issue that must be considered. 
Assuming genotypes are missing at random, we compare type I error rates testing for 
various sets of MFG parameters given 0, 5, 10, and 20% missing genotypes. Here we use 
Simulation A data, randomly removing a percentage of genotypes with each repetition, and 
estimate type I error rates with a per test significance level of 0.05. With all the models 
tested missing data did not significantly affect type I error rates (Table S2).
Screening for MFG Incompatibility Using Pedigree-based GWAS Data
The ability to quickly screen markers is demonstrated by running the QMFG test on data 
from the SAFHS. Missing genotypes for the 944,565 SNPs across the genome were imputed 
using Mendel’s imputation option. We removed 14,008 SNPs (1.48%) because there was at 
least one impossible maternal-offspring genotype combination observed at each of these 
SNPs in the imputation results. We omitted another 295,063 SNPs because they had minor 
allele counts less than 10 leaving a total of 635,494 SNPs for the analysis. Because we have 
no specific hypothesis regarding MFG interactions associated with HDL measures but aim 
to demonstrate the feasibility of using the QMFG test on pedigree-based GWAS data, we 
use an alternative hypothesis of NIMA or offspring effects, a straightforward generalization 
of the standard GWAS analysis. This model takes into account offspring effects, so in the 
case that there is an underlying offspring genotypic effect but no NIMA effect, we lose 
power by including the parameter for NIMA but avoid misspecifying the model.
In these analyses we assume the minor allele of each SNP is the variant allele and include 
sex and age as fixed effects. Under the null hypothesis of no genetic effects, the estimate of 
the grand mean was 48.030 (SE = 2.094). The age effect estimate of 0.034 (SE = 0.069) was 
not significant. Women had significantly higher HDL levels than males (4.222 units higher, 
SE = 1.154). Figures 10 and 11 show the Q-Q plot (λ = 1.012) and Manhattan plot resulting 
from the three degrees of freedom QMFG score test for the alternative hypothesis of NIMA 
or offspring effects. The run time for Mendel to read in and perform the score tests for the 
635,494 SNPs was 4 minutes and 28 seconds on a computer with 12 CPU cores (at 2.67 
GHz). About 0.2% (1309) of sites fall outside the 95% confidence limits of the Q-Q plot 
(Figure 10). The 10 markers with the smallest p-values are shown in Table 4. Figure S14 
shows the Q-Q plot of the same results with the top 10 hits removed (λ = 1.012). The lowest 
p-value, found with SNP rs1547189, corresponds to an FDR (Benjamini & Hochberg, 1995) 
of 7.5% (Table 5). The parameter estimates for this SNP are shown in Table 6.
For rs1547189, we further refine our analysis. The two degrees of freedom test for offspring 
genetic effects for SNP rs1547189 on HDL has a p-value of 0.0007. For the one degree of 
freedom test for additive offspring effects (2β.1 = β.2) using the same SNP, the p-value is 
0.18. We also test for a NIMA effect in the presence of offspring effects adjusting for sex 
and age using an LRT. The p-value of 2.98 × 10−6 suggests that even when accounting for 
offspring genotypic effects, there may be an additional effect of NIMA. Taken together, 
these results suggest that there may be both an underlying recessive offspring effect and a 
NIMA effect on HDL for SNP rs1547189.
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Our simulation studies show that the LRT version of the QMFG test leads to correct 
parameter estimates and inference and the score test version of the QMFG test provides 
equivalent inference to the LRT under both specific and general models of MFG 
incompatibility. The simulations under an RHD incompatibility scenario illustrate the 
QMFG test under a simple model, involving just one MFG parameter. We show that our 
approach has correct type I error rates for the LRT and score test, zero parameter estimation 
bias, and high power even when the proportion of variation explained by MFG 
incompatibility is small. The simulations under NIMA provide a more complicated, but still 
biologically pertinent, scenario to evaluate the properties of the QMFG test, requiring an 
MFG effect and offspring effects to be tested jointly. Under this scenario, the effect on 
offspring with genotypes homozygous for the reference allele depends on their mother’s 
genotype. With this scenario, we show the flexibility of the LRT to test effects jointly, 
marginally, and conditionally. When testing NIMA and offspring effects jointly and 
conditionally, again the LRT version of the QMFG test produces appropriate type I error 
rates, zero parameter estimation bias, and high power. This model can be extended by 
allowing for maternal genetic effects. We also demonstrate that it is possible to impose 
parameter restrictions to test for other situations such as a dominant offspring effects.
Additionally, we investigate MFG incompatibility testing in the case that there is no a priori 
information about the underlying MFG model. As expected, power is reduced when 
applying this general model, which imposes no constraints on the MFG parameters, to data 
simulated with a specific, more restricted MFG incompatibility. Our results indicate that 
even when the general model is fit to the data in place of the correct, simpler model, the 
QMFG LRT still produces unbiased parameter estimates. We also explore cases where the 
model is misspecified such that a model with only offspring effects is fit to data with true 
underlying MFG effects and find that power is greatly reduced. This is especially true in the 
case of testing for additive effects when the underlying MFG effect is RHD incompatibility, 
where power drops down to the type I error rate. This particularly low powered case with the 
additive model results because we have a SNP that, when viewed from the perspective of 
offspring effects, is displaying a weak amount of over-dominance in which a only fraction of 
the offspring with heterozygous genotypes are expected to have different phenotypic values 
from offspring with either of the two homozygous genotypes. In the case of an underlying 
NIMA effect, there is more power to detect a genotypic effect when fitting a model with 
only offspring effects but in this case, the NIMA would be misinterpreted as a weak 
dominant effect on the quantitative trait. These results have implications for GWAS, which 
typically use additive models or Armitage trend tests, since, as we have shown, the genetic 
effects can be detected but misinterpreted, determined with lower power, or missed all 
together. The QMFG test is also subject to type I or type II error when the model is 
misspecified. In particular, when applying the NIMA effect model to data with an RHD 
effect, applying the RHD effect model to data with a NIMA effect, or applying a RHD or 
NIMA model to data with offspring effects, the null hypothesis is rejected at very low rates, 
indicating that in these cases the locus would be missed. Because most effects are very 
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likely to be offspring genotype effects, we recommend using an MFG model that includes 
offspring genetic effects when screening large numbers of SNPs.
Unlike other methods that have been proposed to test for an association between a 
quantitative trait and MFG incompatibility, the QMFG test can handle small and large 
pedigrees simultaneously. With actual data from the SAFHS we verify that the QMFG score 
test is an effective and rapid screening tool for genome wide association studies. In this data 
set, family size varied greatly; the smallest family had 8 members and spanned 3 
generations; the largest family had 176 members and spanned 5 generations. We chose to 
analyze the data by jointly screening for NIMA and offspring genotypic effects using the 
score test. If the genetic effects only come from the offspring as typically assumed, our 
analysis would still be able to detect them, albeit with slightly lower power than in the 
typical GWAS.
Although none of the top ten markers for NIMA or offspring effects have been previously 
shown to be associated with HDL, the WWOX gene has been shown to be associated with 
HDL (Lee et al., 2008, Saez et al., 2010). Our result with the smallest p-value is for SNP 
rs1547189, which is an intron variant in the ubiquitin specific peptidase 12 (USP12) gene, 
with an FDR of 7.5%. Because it is possible that this marker’s effect could be exclusively 
due to offspring effects, we use the LRT with the null hypothesis of only offspring effects 
and the alternative hypothesis of NIMA and offspring effects to test for NIMA effects in the 
possible presence of offspring effects with SNP rs1547189. Combined, our results are 
suggestive of a NIMA effect in the presence of offspring effects. To determine whether this 
association is due to a previously undetected NIMA effect on HDL or, perhaps what is more 
likely is just a type I error, requires testing in other cohorts. However, we have clearly 
demonstrated the potential of the QMFG test to identify novel associations with quantitative 
traits that may not be detected in standard GWAS analysis models, because the standard 
GWAS only considers offspring allelic effects. Additionally, our analysis demonstrates that 
the LRT is a useful tool to refine results following the rapid screening provided by the 
QMFG score test.
To date, no other studies have looked at the role of MFG incompatibility on quantitative 
traits in families larger than trios due to the lack of appropriate models and practical 
software. The QPL method (Kistner & Weinberg, 2005) as well as the QCPG method 
(Wheeler & Cordell, 2007) are both retrospective approaches in which the offspring 
genotype is modeled as a function of the quantitative trait and parental genotypes and are 
restricted to parent-offspring trios. These methods can be easily modified to test for 
maternal-offspring gene interactions (Wheeler & Cordell, 2007). However, Wheeler and 
Cordell’s simulation results suggest that, compared to these two retrospective approaches to 
test for quantitative trait association in trios, a prospective, linear regression approach such 
as ours is likely to be more efficient but more sensitive to departures from normality. From 
our viewpoint, the main difficulty with retrospective approaches such as the QPL and QCPG 
is in generalizing them to work with a dataset composed of dramatically different sized 
families. Another limitation is the interpretation of the estimated effects as they are scaled 
by the unknown trait variance. Furthermore, including covariates such as age and sex is not 
straightforward. With the QMFG test we have demonstrated the benefits of a prospective 
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approach to rapidly test for MFG incompatibility in families of any size. It is a highly 
flexible and accurate method, which is also easy to execute with our user-friendly software.
It should be noted that in general, LMMs used for quantitative traits do not directly apply to 
binary phenotypes. This limitation results from the fact that the phenotypic variance of a 
dichotomous disease or trait depends on its incidence in the population (Falconer, 1965). 
Thus, estimates must be rescaled. Unlike with continuous traits, case-control studies are 
additionally susceptible to ascertainment bias. As a result, using LMMs on binary traits 
directly can result in loss of power as sample size increases, likely due to the amplification 
of inaccuracies caused by ascertainment bias (Yang et al., 2014). Methods to improve power 
for qualitative outcomes are based on a liability threshold principle, in which it is assumed 
that binary traits can be represented by an underlying normally distributed liability trait. If 
an individual’s liability exceeds a threshold, then he or she has a phenotypic value of 1, 
otherwise 0, with the proportion of the normal distribution that exceeds the threshold being 
equal to trait incidence (Dempster & Lerner, 1950, Falconer, 1965). An approach by Hayeck 
et al. (2015) estimates the posterior mean liability (PML) of each individual conditional on 
the case-control status of all subjects, disease prevalence, and liability scale phenotypic 
covariance. The association between each SNP and PML is then tested. Accordingly, if the 
QMFG test is applied to dichotomous data, it is recommended that one adopt the Hayeck et 
al. (2015) approach.
We have implemented the QMFG test by modifying the statistical genetics software package 
Mendel. This option is scheduled for release in an upcoming version of Mendel. The validity 
of our method, together with the availability of convenient software, make the QMFG test a 
powerful tool for detecting undiscovered associations with complex diseases.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Pedigree depiction of the Rhesus factor D (RHD) scenario
The mother has two variant alleles (d/d). Offspring A has two variant alleles (d/d). Offspring 
B has one variant allele (D/d) and is therefore RHD incompatible with the mother.
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Figure 2. Pedigree depiction of the non-inherited maternal antigen (NIMA) scenario
The mother has one variant allele encoding a shared epitope (SE+/SE−). Offspring A has 
two variant alleles encoding a shared epitope (SE+/SE+). Offspring B has no variant alleles 
encoding a shared epitope (SE−/SE−) and therefore illustrates the NIMA scenario.
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Figure 3. Q-Q plot for LRT using Simulation A data
Genotypes and quantitative traits for each replication were simulated for 1,000 pedigrees 
under the null of no MFG effects and were tested with the LRT for (a) RHD effects (df = 1, 
λ = 1.065), (b) NIMA or offspring effects (df = 3, λ = 0.989), (c) NIMA effects in the 
presence of offspring genotype effects (df = 1, λ = 1.048), (d) offspring effects in the 
presence of NIMA effects (df = 2, λ = 0.959), and (e) any MFG effects (df = 6, λ = 1.086).
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Figure 4. Parameter estimate bias
Genotypes and quantitative traits for each replication were simulated for 1,000 pedigrees 
using (a) Simulation B data with an RHD effect of 0.55 (μ = 40, β21 = 0.55, ), 
(b) Simulation C data with a NIMA effect of 0.60 and an additive offspring allelic effect of 
0.18 (μ = 40, β10 = 0.60, β.1 = 0.18, β.2 = 0.36, ), and (c) Simulation G data with 
a variant allele count effect of 0.17 (μ = 40, β01 = 0.17, β10 = 0.17, β11 = 0.34, β12 = 0.51, β21 
= 0.51, β22 = 0.68, ). Boxplots show bias of parameter estimates, additive 
genetic variance, and environmental variance over 2,000 replications. A horizontal line is 
drawn at zero bias.
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Figure 5. RHD incompatibility and NIMA power curves
(a) Solid lines show power for the one degree of freedom test for an RHD effect (β21) using 
the LRT and score test. Dotted lines show power when there is no specific MFG hypothesis 
(so all 6 MFG parameters are tested) using the LRT and score test. RHD effect sizes range 
from 0 to 0.7. Error bars represent approximate 95% confidence intervals. (b) Solid lines 
show power for the three degrees of freedom test for NIMA or offspring effects (β10, β.1, β.2) 
using the LRT and score test. Dotted lines show power when there is no specific MFG 
hypothesis (so all 6 MFG parameters are tested) using the LRT and score test. NIMA effect 
sizes β10 range from 0 to 0.7 and offspring effects are fixed (β.1 = 0.18, β.2 = 0.36). The 
power is not 0.001 and the proportion of variation explained is not zero when β10 = 0 
because β.1, β.2 are not zero. Error bars represent approximate 95% confidence intervals.
CLARK et al. Page 24













Figure 6. Parameter estimate bias when data are simulated under RHD incompatibility with a 
smaller sample size
Boxplots show bias of parameter estimates for the grand mean, MFG effects, additive 
genetic variance, and environmental variance using 100 three-generational families over 
2,000 replications using parameters from Simulation E with an RHD effect of 1.75 (μ=40, 
β21 =1.75, ). A horizontal line is drawn at zero bias.
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Figure 7. Power using an offspring effect only test for data simulated under RHD incompatibility
RHD effect sizes range from 0 to 0.7. Solid lines show the power for fitting the genotypic 
model, i.e., the two degrees of freedom test for offspring effects (β.1, β.2). Dotted lines show 
the power for fitting the additive model, i.e., the one degree of freedom test with the added 
constraint 2β.1 = β.2. Error bars represent approximate 95% confidence intervals. (a) Curves 
show power using the LRT and score test at significance level α=0.05. (b) Curves show 
power using the LRT and score test at significance level α=0.001.
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Figure 8. Power using an offspring effect only test for data simulated under a NIMA effect
Curves show power using the LRT and score test at significance level α = 0.001. NIMA 
effect sizes range from 0 to 0.7. Solid lines show the power for fitting the genotypic model, 
i.e., the two degrees of freedom test for offspring effects (β.1, β.2). Dotted lines show the 
power for fitting the additive model, i.e., the one degree of freedom test with the added 
constraint 2β.1 = β.2. Error bars represent approximate 95% confidence intervals.
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Figure 9. Parameter estimate bias due to model misspecification
Genotypes and quantitative traits for each replication were simulated for 1,000 pedigrees 
using Simulation J data with an offspring allelic effect of 0.27 (μ = 40, β.1 = 0.27, β.2= 0.54, 
). Boxplot shows bias of parameter estimates, additive variance, and 
environmental variance over 2,000 replications when the model is misspecified as (a) Model 
2, the RHD effect model, (b) Model 3, the NIMA and offspring effects model, (c) Model 5, 
the NIMA effect model, and (d) Model 8, the general model. A horizontal line is drawn at 
zero bias.
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Figure 10. Q-Q plot for score test of the SAFHS data
Results from the three degrees of freedom test for NIMA or offspring effects (β10, β.1, β.2) 
using the score test adjusting for age and sex (λ = 1.012). Data from the SAFHS consist of 
635,494 SNPs from 419 offspring with HDL measurements in 43 multi-generational 
families.
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Figure 11. Manhattan plot for score test of the SAFHS data
Results from the three degrees of freedom test for NIMA or offspring effects (β10, β.1, β.2) 
using the score test adjusting for age and sex. Data from the SAFHS consists of 635,494 
SNPs from 419 offspring with HDL measurements in 43 multi-generational families. A 
dashed horizontal line is drawn at the initial significance cutoff for an FDR of 10%.
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Table 1
QMFG model parameterizations
GMat and GOff denote the maternal and offspring genotypes, respectively.
GMat GOff General QMFG model RHD effects NIMA and offspring effects
1/1 1/1 β00 β00 β00
1/1 1/2 β01 β00 β.1
1/2 1/1 β10 β00 β10
1/2 1/2 β11 β00 β.1
1/2 2/2 β12 β00 β.2
2/2 1/2 β21 β21 β.1
2/2 2/2 β22 β00 β.2
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Table 3
QMFG full and reduced models.
Models Number of MFG parameters estimated MFG parameters estimated
1 No genetic effects model 0 None
2 RHD effect model 1 β21




4 Offspring effects model 2
β01 =β11 =β21
β12 = β22
5 NIMA effect model 1 β10
6 NIMA and dominant offspring effects model 2
β10
β01 =β11 =β21= β12=β22
7 NIMA, offspring, and maternal effects model 5
β01, β10, β11, β12, β21
β22 = β12 + β21 − β11
8 General model 6 β01, β10, β11, β12, β21, β22
9 Additive offspring effect model 1 2β01 = 2β11 = 2β21 =β12 = β22
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Table 4
Score test for NIMA or offspring effects on HDL from the San Antonio Family Heart Study.
Chromosome Nearby gene SNP Score test statistic P-value
13 USP12 rs1547189:G>A 35.1 1.16 × 10−7
5 - rs9293660:G>A 32.6 3.91 × 10−7
17 NGFR rs614455:T>C 31.9 5.49 × 10−7
1 FAM69A rs7521417:C>T 30.9 8.92 × 10−7
8 LOC102723729 rs11987150:G>A 30.6 1.03 × 10−6
19 ZNF888 rs10425203:G>A 30.5 1.08 × 10−6
8 GINS4 rs13265966:T>C 30.0 1.38 × 10−6
8 LOC102723729 rs11994079:G>T 29.6 1.68 × 10−6
16 - rs6564175:T>C 28.9 2.35 × 10−6
16 WWOX rs4267317:G>A 27.9 3.81 × 10−6
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Table 5
False discovery rates for the San Antonio Family Heart Study analysis.
FDR P-value threshold Number of significant SNPs
5% 7.87 × 10−8 0
7.5% 1.18 × 10−7 1
10% 1.57 × 10−7 1
15% 1.89 × 10−6 8
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Table 6
Parameter estimates for SNP rs1547189 from the SAFHS data.
Effect Parameter Estimate Std Error
Grand mean μ 46.10 2.72
NIMA β10 8.51 2.15
A/G* offspring β.1 −0.60 1.85
G/G offspring β.2 10.19 2.84
Female βfemale 4.32 0.55
Age βage 0.04 0.07
Additive variance 80.66 19.64
Environmental variance 63.60 14.60
*
G is the minor allele for SNP rs1547189
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